Efficacy, Safety, and Patient-Reported Outcomes of Atezolizumab Plus Bevacizumab for Unresectable Hepatocellular Carcinoma in Thailand: A Multicenter Prospective Study
Article in JCO Global Oncology (December 2022)
The most recent citing publications are shown below. View all 3 publications that cite this research output on Dimensions.
Editorial: Cancer therapy: The challenge of handling a double-edged sword
Article in Frontiers in Pharmacology (September 2022)
Efficacy and Safety of Atezolizumab and Bevacizumab in the Real-World Treatment of Advanced Hepatocellular Carcinoma: Experience from Four Tertiary Centers
Article in Cancers (March 2022)